Studies have reported that drugs injected with antivascular endothelial growth factors in the glass cavity can promote the absorption of retinal fluid and re-reset away from the retina, and studies have found that the glass cavity injection anti-VEGF drug alone or as an auxiliary treatment of Coats disease under the retina, which provides a new option for clinical treatment of patients with severely ill Coats.
正在翻译中..